Avivagen Inc. Announces Closing of First Tranche of a Non-Brokered Private Placement of Shares for Proceeds of up to $1.0 Million

[AJBot]

OTTAWA, Ontario -- Avivagen Inc. (TSXV:VIV) (“Avivagen” or the “Company”), a life sciences corporation focused on developing and commercializing products for livestock, companion animal and human applications that safely enhance and support immune function, thereby supporting general health and performance, announces that it has closed the first tranche (the “First Tranche”) of a non-brokered private placement financing of up to $1,000,000 (the “Offering”) through the issuance of common shares of the Company (each, a “Common Share”) at a price of $0.20 per Share (the “Of ...

Continue reading the above news article, by clicking here.

Administration and Moderation NOTE: A Reminder, the above news is provided for free, through a RSS Feed. The above quote does NOT include the full story. In order to continue to read more past what is quoted, please click through to the article, by clicking on the link provided above through the "continue reading" text.

Please be sensible and follow our terms of service and rules, when replying and debating the news article.